Txa
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
276 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Hemorrhage | D006470 | MP_0001914 | R58 | 13 | 22 | 33 | 32 | 17 | 107 |
| Postpartum hemorrhage | D006473 | — | O72 | 2 | 6 | 13 | 4 | 3 | 26 |
| Surgical blood loss | D016063 | — | — | 3 | 2 | 5 | 9 | 5 | 23 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | 2 | 1 | 4 | 8 | 5 | 20 |
| Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | 2 | — | 8 | 5 | 15 |
| Hip fractures | D006620 | EFO_0003964 | S72.00 | 1 | 2 | 5 | 5 | 2 | 14 |
| Hematoma | D006406 | EFO_0010680 | — | — | 3 | 5 | 5 | — | 12 |
| Postoperative pain | D010149 | — | G89.18 | — | 1 | 2 | 3 | 4 | 10 |
| Wounds and injuries | D014947 | — | T14.8 | 1 | 5 | 2 | 2 | 1 | 10 |
| Postoperative hemorrhage | D019106 | — | — | 2 | 3 | 1 | 2 | 2 | 9 |
Show 82 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Brain injuries | D001930 | — | S06.9 | 1 | 3 | 3 | — | — | 6 |
| Traumatic brain injuries | D000070642 | — | S06 | 1 | 2 | 3 | — | — | 5 |
| Subdural hematoma | D006408 | HP_0100309 | — | — | 2 | 3 | — | — | 4 |
| Covid-19 | D000086382 | — | U07.1 | — | 3 | 1 | — | — | 4 |
| Obstetric labor complications | D007744 | — | — | — | — | 2 | — | 2 | 4 |
| Subdural hematoma chronic | D020200 | — | — | — | 2 | 2 | — | — | 3 |
| Melanosis | D008548 | HP_0001480 | L81.1 | 1 | 2 | 1 | — | — | 3 |
| Hemorrhagic shock | D012771 | — | — | — | — | 3 | — | — | 3 |
| Thrombocytopenia | D013921 | HP_0001873 | D69.6 | 1 | 1 | 2 | — | — | 3 |
| Leiomyoma | D007889 | HP_0000131 | D25 | — | — | 2 | — | — | 2 |
Show 29 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Skin neoplasms | D012878 | EFO_0004198 | C44 | 1 | 1 | — | — | 1 | 3 |
| Blood coagulation disorders | D001778 | EFO_0009314 | D68.9 | 1 | 1 | — | — | 2 | 3 |
| Hemostatic disorders | D020141 | — | — | 1 | 1 | — | — | 2 | 3 |
| Urinary retention | D016055 | HP_0000016 | R33 | 1 | 1 | — | — | — | 1 |
| Urinary bladder neoplasms | D001749 | — | C67 | 1 | 1 | — | — | — | 1 |
| Hematuria | D006417 | HP_0000790 | R31 | 1 | 1 | — | — | — | 1 |
| Patient satisfaction | D017060 | — | — | 1 | 1 | — | — | — | 1 |
| Nurse's role | D024802 | — | — | 1 | 1 | — | — | — | 1 |
| Physician-nurse relations | D019555 | — | — | 1 | 1 | — | — | — | 1 |
| Intervertebral disc degeneration | D055959 | HP_0008419 | — | — | 1 | — | — | — | 1 |
Show 4 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Postoperative complications | D011183 | — | — | 1 | — | — | — | — | 1 |
| Back pain | D001416 | HP_0003418 | M54 | 1 | — | — | — | — | 1 |
| Hysterectomy | D007044 | EFO_0003881 | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart diseases | D006331 | EFO_0003777 | I51.9 | — | — | — | — | 4 | 4 |
| Fibrinolysis | D005342 | — | — | — | — | — | — | 4 | 4 |
| Congenital heart defects | D006330 | HP_0001627 | Q24.9 | — | — | — | — | 3 | 3 |
| Musculoskeletal diseases | D009140 | — | — | — | — | — | — | 1 | 1 |
| Acupuncture therapy | D015670 | — | — | — | — | — | — | 1 | 1 |
| Seizures | D012640 | HP_0002069 | G40.4 | — | — | — | — | 1 | 1 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | — | — | — | 1 | 1 |
| Ovarian epithelial carcinoma | D000077216 | — | — | — | — | — | — | 1 | 1 |
| Hyperpigmentation | D017495 | HP_0000953 | — | — | — | — | — | 1 | 1 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | — | — | — | 1 | 1 |
Show 16 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use